[HTML][HTML] iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
KM Snyder, KJ Dixon, Z Davis, M Hosking… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
[HTML][HTML] iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
KM Snyder, KJ Dixon, Z Davis, M Hosking… - … for ImmunoTherapy of …, 2023 - jitc.bmj.com
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
KM Snyder, K Dixon, Z Davis, M Hosking… - … for ImmunoTherapy of …, 2023 - experts.umn.edu
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
KM Snyder, KJ Dixon, Z Davis, M Hosking… - … for Immunotherapy of …, 2023 - europepmc.org
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
KM Snyder, KJ Dixon, Z Davis… - Journal for …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
KM Snyder, KJ Dixon, Z Davis… - Journal for …, 2023 - search.proquest.com
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
KM Snyder, KJ Dixon, Z Davis, M Hosking… - … for Immunotherapy of …, 2023 - europepmc.org
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-
associated cells, and suppressive immune cells to mediate antibody-dependent cell …
associated cells, and suppressive immune cells to mediate antibody-dependent cell …